![Dialysis patients benefit from a third Covid vaccination dose - Newsportal - Ruhr-Universität Bochum Dialysis patients benefit from a third Covid vaccination dose - Newsportal - Ruhr-Universität Bochum](https://news.rub.de/sites/default/files/styles/nepo_teaser/public/foto-drittimpfung_roland_hentschel-angepasst.jpg?itok=k9GIFBNJ)
Dialysis patients benefit from a third Covid vaccination dose - Newsportal - Ruhr-Universität Bochum
![Viruses | Free Full-Text | Longitudinal Analysis of Coronavirus-Neutralizing Activity in COVID-19 Patients | HTML Viruses | Free Full-Text | Longitudinal Analysis of Coronavirus-Neutralizing Activity in COVID-19 Patients | HTML](https://www.mdpi.com/viruses/viruses-14-00882/article_deploy/html/images/viruses-14-00882-g001.png)
Viruses | Free Full-Text | Longitudinal Analysis of Coronavirus-Neutralizing Activity in COVID-19 Patients | HTML
![Biomedicines | Free Full-Text | COVID-19 Infection Induce miR-371a-3p Upregulation Resulting in Influence on Male Fertility | HTML Biomedicines | Free Full-Text | COVID-19 Infection Induce miR-371a-3p Upregulation Resulting in Influence on Male Fertility | HTML](https://www.mdpi.com/biomedicines/biomedicines-10-00858/article_deploy/html/images/biomedicines-10-00858-g001.png)
Biomedicines | Free Full-Text | COVID-19 Infection Induce miR-371a-3p Upregulation Resulting in Influence on Male Fertility | HTML
Protein Corona Formation on Colloidal Polymeric Nanoparticles and Polymeric Nanogels: Impact on Cellular Uptake, Toxicity, Immunogenicity, and Drug Release Properties | Biomacromolecules
![A SARS-CoV-2 neutralizing antibody selected from COVID-19 patients binds to the ACE2-RBD interface and is tolerant to most known RBD mutations - ScienceDirect A SARS-CoV-2 neutralizing antibody selected from COVID-19 patients binds to the ACE2-RBD interface and is tolerant to most known RBD mutations - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2211124721008500-fx1.jpg)
A SARS-CoV-2 neutralizing antibody selected from COVID-19 patients binds to the ACE2-RBD interface and is tolerant to most known RBD mutations - ScienceDirect
![Preparation and Characterization of ACE2 Receptor Inhibitor-Loaded Chitosan Hydrogels for Nasal Formulation to Reduce the Risk of COVID-19 Viral Infection | ACS Omega Preparation and Characterization of ACE2 Receptor Inhibitor-Loaded Chitosan Hydrogels for Nasal Formulation to Reduce the Risk of COVID-19 Viral Infection | ACS Omega](https://pubs.acs.org/cms/10.1021/acsomega.1c05149/asset/images/large/ao1c05149_0020.jpeg)